Breast Cancer

Breast cancer survivors who harbor BRCA gene mutation are at elevated risk for second primary cancers, according to study results.

Cancer incidence has continued to rise in the U.S. since the 1990s — particularly among women and younger adults, according to an American Cancer Society report.

Adjuvant ado-trastuzumab emtansine significantly prolonged survival compared with trastuzumab for certain women with HER2-positive breast cancer, according to long-term results of a randomized phase 3 trial.

An American Society of Radiation Oncology survey has shined a spotlight on the impact prior authorization has on providers and patients.

SAN ANTONIO — The addition of camrelizumab to platinum-containing intensive neoadjuvant chemotherapy improved pathologic complete response for certain patients with triple-negative breast cancer.

The CDC has awarded Weill Cornell Medicine a 5-year, $2.3 million grant to advance equitable access to care for young patients with breast cancer.

Weight gain after a breast cancer diagnosis elevated a person’s risk for heart failure, according to results of an observational study in the Republic of Korea.

One in eight women will suffer from breast cancer in their lifetime. Eight percent will decline treatment due to the fear of alopecia.

Regular physical activity prior to a cancer diagnosis lowered a patient’s risk for disease progression and death, according to study findings.

Incorporating digital screening tools and patient education into obstetrics and gynecology care may improve hereditary cancer risk assessment and genetic testing completion, according to study results published in Obstetrics & Gynecology.